C2N Diagnostics

C2N Diagnostics company information, Employees & Contact Information

Explore related pages

Related company profiles:

C₂N Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring. Its lead commercial product, the PrecivityAD™ blood test, is a mass spectrometry-based test performed in C₂N’s CLIA-certified lab that measures in blood multiple analytes including Aβ42, Aβ40, and apolipoprotein E isoforms. While the test by itself cannot diagnose Alzheimer’s disease — which is a clinical diagnosis made by a health care provider — the test is an important new tool for physicians to aid in the evaluation process. PrecivityAD™, which can only be ordered through a health care provider, predicts brain amyloid plaques as determined by PET scan results and in 2019 it received a Breakthrough Device Designation from the U.S. Food and Drug Administration. The PrecivityAD™ blood test also has achieved the CE Mark from the European Union. For more information visit www.C2N.com.

Company Details

Employees
105
Founded
-
Address
20 S Sarah St, St Louis,missouri 63108,united States
Phone
314-633-1884
Email
in****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Maitland.
HQ
St Louis, Missouri
Looking for a particular C2N Diagnostics employee's phone or email?

C2n Diagnostics Questions

News

Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M - Fierce Biotech

Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M Fierce Biotech

Samsung Invests in C2N Diagnostics - Business Wire

Samsung Invests in C2N Diagnostics Business Wire

C2N Diagnostics lands $10m cash injection from Samsung - Medical Device Network

C2N Diagnostics lands $10m cash injection from Samsung Medical Device Network

Samsung life science fund invests $10M in C2N Diagnostics - BioWorld MedTech

Samsung life science fund invests $10M in C2N Diagnostics BioWorld MedTech

C2N Diagnostics Partners with The Michael J. Fox Foundation to Uncover New Links Between Parkinson’s Disease, Lewy Body Dementia and Alzheimer’s Disease - Business Wire

C2N Diagnostics Partners with The Michael J. Fox Foundation to Uncover New Links Between Parkinson’s Disease, Lewy Body Dementia and Alzheimer’s Disease Business Wire

Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests - Fierce Biotech

Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests Fierce Biotech

C2N Diagnostics launches revamped Alzheimer's blood test - Fierce Biotech

C2N Diagnostics launches revamped Alzheimer's blood test Fierce Biotech

Top C2N Diagnostics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant